Revvity
If they say “impossible,” we say “challenge accepted.” At Revvity, we fearlessly face tomorrow’s unknowns for a healthier humankind.
Content by Revvity
|1 min read
Standardizing Oncology Assays: A Guide to Cell Line-Derived Reference Materials
Identify the limitations of patient tissue controls in genetic testing and examine the verification data supporting cell line-derived standardsSponsored by
|1 min read
Move Past the Limitations of Synthetic Reference Standards in Cancer Research
A review of cell line-derived reference standards for the investigation and molecular profiling of myeloid malignanciesSponsored by
|2 min read
Revvity Expands Alliance with Genomics England to Drive Research into Newborn Genomic Sequencing in England
New agreement to support newborn health adds sequencing lab services to the existing extraction services collaboration
|1 min read
Revvity Announces FDA Clearance for First Automated Free Testosterone Test
This innovative test is the first of its kind to receive FDA clearance for direct quantitative measurement of free testosterone levels
Updated |2 min read
Unlocking the Possibilities in Cancer Research with Revvity
Revvity presented their diverse portfolio of cancer research tools at AACR, reaffirming their commitment to empowering researchers
|1 min read
Revvity Signals Software’s New Synergy Solution Redefines Collaboration Between Pharma and Contract Partners
New CRO system-level expansion elevates data stewardship and enables organizations to gain more insight with less oversight
|2 min read
Accelerating NGS Library Prep with the New Fontus Workstation
Easy-to-use software and access to a dedicated support team reduces start up time and optimizes workflowPage 1 of 1
